Global High-Flow Nasal Cannula Market Is Estimated To Surge at CAGR Of 12% by 2033

Over the five-year period from 2023 to 2033, it is predicted that sales of high-flow nasal cannulas will grow at a rapid CAGR of 12%. By 2033, the market, which is currently valued at US$ 7.7 billion, is anticipated to have grown to US$ 24 billion.

Because hospitals have state-of-the-art medical facilities, patients with chronic obstructive lung illnesses prefer them. Due to their advantages, including a lower risk of infection and the perfect flow rate, high-flow nasal cannulas are frequently used in hospitals to treat respiratory conditions. Up to 100% heated, humidified oxygen can be delivered at a flow rate of up to 60 litres per minute using a device known as a high-flow nasal cannula. As a substitute for traditional respiratory support, high-flow nasal cannulas are becoming more popular.

For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4777?SP

Key Takeaways:

  • North America is likely to hold a 50% share in the global high-flow nasal cannula market from 2023 to 2033.
  • Japan market is slated to accelerate at an impressive 11% CAGR in the global market from 2023 to 2033.
  • Germany is likely to dominate the Europe high-flow nasal cannula market.
  • By component, nasal cannulas is set to account for 60% shares in the global market between 2023 and 2033.
  • Based on application, acute respiratory failure is poised to generate significant revenue.

Competitive Landscape:

Top high-flow nasal cannula providers are consistently innovating their product portfolios through technological advancements to acquire market presence. Key market players are making high investments in R&D projects to enhance quality control of products using advanced technologies and following safety regulations to reduce the environmental impact.

Major high-flow nasal cannula manufacturers are focusing on producing top-notch cannulas and distributing them to clinics, hospitals, and healthcare institutions. Leading companies in the high-flow nasal cannula market use a variety of strategies to boost sales across numerous geographies, including improving product standards, collaborations, and supply chain management.

For instance,

  • Fisher & Paykel Healthcare is a leading player in the global high-flow nasal cannula market. Its flagship products include F&P 950 Humidifier, Optiflow High-flow System, and the AIRVO 2. Other products include OptiFlowTM Nasal High, F&P Brevida Masks, and the F&P SimplusTM Full Face Masks.
  • ResMed Inc. is another market leader in the respiratory therapy market. It offers a strong product portfolio for the treatment of sleep apnea and non-invasive ventilation. Its flagship products include AirView, myAir, and ClimateLine MAX for the treatment and management of sleep apnea and respiratory disorders.
  • In August 2021, ResMed introduced AirSense 11, its newest positive airway pressure (PAP) device for treating and controlling obstructive sleep apnea.

Key Segments of High-Flow Nasal Cannula Industry Research:

·         By Component :

  • Air/Oxygen Blenders
  • Air Humidifiers
  • Single Heated Tubes
  • Nasal Cannulas
  • Others

·         By Application :

  • Acute Respiratory Failure
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Carbon Monoxide Toxicity
  • Bronchiectasis
  • Sleep Apnea
  • Others

·         By End User :

  • Hospitals
  • Long-term Care Centers
  • Ambulatory Care Centers
  • Others

·         By Region :

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

For in-depth competitive analysis, Buy Now:
https://www.factmr.com/checkout/4777

Growth Drivers:

  • The use of high-flow nasal cannulas to treat hypoxemic and hypercapnic respiratory failure is likely to increase demand.
  • Increasing prevalence of sleep apnea should fuel the need for high-flow nasal cannulas.
  • Increasing investments in research & development initiatives for the development of technological advancements is set to spur market expansion.

Restraints:

  • Availability of substitutes in the market is projected to hinder the sales of high-flow nasal cannula.
  • Long-term use of high-flow nasal cannulas can trigger several side effects and is likely to impede market acceleration.

Key Questions Covered in the High-flow Nasal Cannula Market Report

  • What is the projected value of the high-flow nasal cannula market in 2023?
  • At what rate will the global high-flow nasal cannula market grow until 2033?
  • Which are the factors hampering the growth in high-flow nasal cannula market?
  • Which region is expected to lead in the global high-flow nasal cannula market between 2023 and 2033?
  • Which factors are likely to drive the high-flow nasal cannula market from 2023 to 2033?

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com